Why SMART about second-line treatment when first-line treatment is being ignored?
- PMID: 16963701
- DOI: 10.1378/chest.130.3.929
Why SMART about second-line treatment when first-line treatment is being ignored?
Comment on
-
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.Chest. 2006 Jan;129(1):15-26. doi: 10.1378/chest.129.1.15. Chest. 2006. PMID: 16424409 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
